5 medicines held by Piramal Critical Care B.V. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Rapifen 500 micrograms/ml solution for injection or infusion PA22583/001/001 |
ALFENTANIL HYDROCHLORIDE | Piramal Critical Care B.V. | Not marketed |
| Sevoflurane 100% Inhalation Vapour, liquid PA22583/003/001 |
Sevoflurane | Piramal Critical Care B.V. | Marketed |
| Sublimaze 50 micrograms/ml solution for injection PA22583/002/001 |
FENTANYL CITRATE | Piramal Critical Care B.V. | Not marketed |
| Sugammadex Piramal 100 mg/mL solution for injection EU/1/23/1739/001-002 |
Sugammadex sodium | Piramal Critical Care B.V. | — |
| Yargesa 100 mg hard capsules EU/1/17/1176/001 |
Miglustat | Piramal Critical Care B.V. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.